Skip to main content

Table 2 The result of examination on patients in the conference

From: Phenotypic diversity in an international Cure VCP Disease registry

 

Total participants (n = 22)

Participant sex (M:F)

10:12

Age at onset (n = 19)a

43.4 ± 8.9

Age at diagnosis (n = 17)a

49 ± 7.9

Age at participationa

55.2 ± 9.9

Forced vital capacity, % predictedb (range)

82 ± 25 (48–146)

ALS-CBSb,c (range)

17.1 ± 1.6 (14–20)

Facial weakness

11 (50%)

Weakness of eye closure

7 (32%)

Weakness of lip closure

9 (41%)

Scapular winging

12 (55%)

Bilateral

5 (23%)

Unilateral

7 (32%)

IBM-FRSb,d (range)

29.0 ± 7.0 (9–39)

Timed up and go testb,e (n = 17, s, range)

12.2 ± 6.0 (5.0–27.6)

Walking aid

14 (64%)

Cane

9 (41%)f

Walker

11(50%)g

Wheelchair

5 (23%)h

  1. aMean ± SD, years
  2. bMean ± SD
  3. cAmyotrophic Lateral Sclerosis Cognitive Behavioral Screen (ALS-CBS) is a screening tool for frontal lobe dysfunction. We used the cognitive section of ALS-CBS whose total score is 20
  4. dInclusion Body Myositis Functional Rating Scale (IBM-FRS) consists of 10 questions about a patient’s ability to perform daily activities, such as walking, dressing, and handling utensils. Each question was answered using a number 0–4
  5. eThe Timed Up and Go test is a test for quantifying functional mobility and assessing the fall risk, in which the ability to rise from a seated chair position, walk 3 m, turn, walk back, and sit down is timed
  6. fAmong the nine patients, five patients always used a cane, while four patients only sometimes used it
  7. gAmong the eleven patients, two patients always used a walker, while nine patients only sometimes used it
  8. hAmong the five patients, one patient always used a wheelchair, while four patients only sometimes used it